RVHL · Real Estate · Real Estate - Development
Composite scorecard: 78/100 — Quality 89 · Valuation 100 · Momentum 18
| Share price | ₹45.51 |
| Market cap | ₹276 Cr |
| P/E ratio | 5.6 |
| P/B ratio | 1.0 |
| ROCE | 22.5% |
| Book value | ₹47.33 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹75 Cr | ₹49 Cr | 83.0% |
| 2025 | ₹0 Cr | ₹-3 Cr | -1,326.0% |
| 2024 | ₹1 Cr | ₹-2 Cr | -1,437.0% |
| 2023 | ₹12 Cr | ₹6 Cr | 21.0% |
| 2022 | ₹0 Cr | ₹0 Cr | -9,933.0% |
Ravinder Heights Limited engages in the real estate business in India. The company is involved in the acquisition, construction, development of townships built-up infrastructure, housing, commercial premises, hotels, resorts, hospital, educational institution, recreational facilities, city and regional level infrastructure. It rents its properties. The company was incorporated in 2019 and is based in New Delhi, India. Ravinder Heights Limited is a subsidiary of Panacea Biotec Limited.